TheWealthWeb

HDFC Pharma and Healthcare Fund Direct IDCW

HDFC Mutual FundEquity Scheme - Sectoral/ ThematicDirect · IDCWRisk: Very High Risk

NAV ₹23.493 on 13 November 2026

AMFI name: HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan · Scheme code 152081

1 year
+31.60%
3 years, a year
+31.28%
Since launch, a year
+31.75%

IDCW option: returns are NAV changes and leave out payouts, so they understate what investors received. Risk ratios are not shown for payout options.

NAV performance, last year

Returns

To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.

PeriodThis fundNIFTY HEALTHCARE INDEX TRICategory median
1M+10.43%+8.67%+5.71%
6M+18.36%+12.84%+7.79%
1Y+31.60%+38.92%+4.11%
3Y+31.28%+28.05%+14.35%
5Y--+12.25%

Benchmark: NIFTY HEALTHCARE INDEX TRI (total return index), measured over the same dates. The scheme document names BSE Healthcare Index (TRI), which we do not hold, so this is the closest NSE index.

Category median: the middle return among Direct plans (Growth option) in AMFI's “Equity Scheme - Sectoral/ Thematic” category, up to 174 funds with clean data. Ranks are under “Rank among peers”.

Rank among peers

Direct plans, Growth option, in AMFI's “Equity Scheme - Sectoral/ Thematic” category. Each rank counts only the peers that have that figure.

Compare with Top Peers
3-Year Return Rank
-of 8
+31.28%
N/A
Q1
Q2
Q3
Q4
1-Year Return Rank
-of 8
+31.60%
N/A
Q1
Q2
Q3
Q4
Sharpe (Risk-Adjusted)
-of 8
-
N/A
Q1
Q2
Q3
Q4
Highest 3-year returns in the categoryDirect plans · Growth option
RankScheme Name3Y Return1Y ReturnSharpeDirect TERAUM
#1
Nippon India Mutual Fund
+46.52%+60.64%1.071.06%₹1,100 Cr
#2
HDFC Mutual Fund
+33.64%+20.34%1.070.89%₹11,128 Cr
#3
HDFC Mutual Fund
+31.28%+31.60%1.761.03%₹3,128 Cr
#4
SBI Mutual Fund
+25.42%+26.07%1.470.76%₹5,565 Cr
#5
HDFC Mutual Fund
+24.77%+10.10%1.091.10%₹1,997 Cr
#6
Mirae Asset Mutual Fund
+24.42%+27.89%1.28-₹3,458 Cr
#7
UTI Mutual Fund
+23.89%+22.00%1.311.35%₹1,399 Cr
#8
ICICI Prudential Mutual Fund
+22.73%+10.29%0.952.08%₹3,926 Cr
#-
HDFC Pharma and Healthcare FundCurrent Fund
HDFC Mutual Fund
+31.28%+31.60%-1.03%₹3,128 Cr

Costs and fund facts

Expense ratio (stated maximum)
Direct 1.03% · Regular 2.11%
Exit load
In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched out after 30 days from the date of allotment.
Fund size (all plans)
₹3,128 CrAverage, quarter to September 2026
Benchmark
BSE Healthcare Index (TRI)Compared here with NIFTY HEALTHCARE INDEX TRI
Allotment date
4 October 2023Scheme document
Type
An open-ended equity scheme investing in Pharma and healthcare sector
AMFI scheme code
152081

Fund managers (3)

  • Nikhil Mathur
  • Gopal Agrawal
  • Bhagyesh Kagalkar

How each manager has done since taking over: fund manager scorecard.

Investment objective

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.

From the scheme summary document filed with AMFI.

SIP calculator

A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.

IDCW option: values use the NAV only and leave out the payouts, so they understate what an investor received. The Growth option of this fund shows the full return.

Monthly SIP Amount₹10,000
Investment Horizon5 Years
Simulating monthly 1st from 4 Oct 2023 to 13 Nov 2026
Total Invested38 mos
₹3,80,000
Units: 24,421.47
Current Portfolio Value
₹5,73,734
At latest recorded NAV
Total Profit
+₹1,93,734
+51.0% absolute return
SIP XIRR
27.87%
Annualised, money-weighted
Wealth CompositionProfit is 51% of total invested capital
Invested: ₹3,80,000Profit Generated: ₹1,93,734
Same SIP in the benchmark (NIFTY HEALTHCARE INDEX TRI)Same dates & amounts
Scheme SIP Valuation
₹5,73,734
27.9% XIRR
Benchmark SIP Valuation
₹5,56,767
25.8% XIRR
Fund minus benchmark
+₹16,967
Over 38 monthly installments
SIP instalments are bought on the first NAV date of each month; values use the latest NAV we hold. Past returns are not a guide to future returns.

About this fund

HDFC Pharma and Healthcare Fund Direct IDCW is a mutual fund scheme from HDFC Mutual Fund, listed by AMFI under “Equity Scheme - Sectoral/ Thematic”. This page covers the Direct plan with the IDCW option. Its NAV was ₹23.493 on 13 November 2026. Its NAV changed by 31.60% over 1 year and 31.28% a year over 3 years. These figures leave out IDCW payouts, so they understate what investors received. Its benchmark, NIFTY HEALTHCARE INDEX TRI, returned 28.05% a year over 3 years. The fund house rates its risk as “Very High Risk” on the SEBI riskometer. Its average assets under management were ₹3,128 Cr across all plans for the quarter ending September 2026, as reported to AMFI. Its scheme summary document states a maximum expense ratio (TER) of 1.03% a year for the Direct plan. Managed by Nikhil Mathur, Gopal Agrawal and Bhagyesh Kagalkar. Its scheme summary document gives the allotment date as 4 October 2023.

Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns.

Plans and options of this fund (4)

PlanOptionISINAMFI codeNAV
DirectGrowthINF179KC1HO1-₹23.4913 Nov 2026
DirectIDCWINF179KC1HQ6--
RegularGrowthINF179KC1HL7-₹22.6513 Nov 2026
RegularIDCWINF179KC1HN3--